Gujarat Kidney and Super Speciality IPO: Company sets price band at Rs 108 – Rs 114 per share. Check GMP, other details

Gujarat Kidney and Super Speciality has fixed the price band for its upcoming initial public offering (IPO) at Rs 108 - Rs 114 per equity share. The Rs 251 crore issue will open for public bidding on Monday, December 22, 2025, and close on Wednesday, December 24, 2025.

About Gujarat Kidney and Super Speciality IPO

The mainboard IPO is a fresh issue of up to 2.2 crore equity shares, and the investors can bid for a minimum of 128 equity shares and in multiples of 128 equity shares thereafter.


The offer is being made through the book-building process, where up to 75% of the net offer is allocated to qualified institutional buyers (QIBs) while a 15% quota is assigned for non-institutional investors (NIIs). The company has allocated a 10% portion for retail investors.

About the company

The company is one of the regional healthcare companies located in the central region of Gujarat and operates a chain of mid-sized multi-speciality hospitals, providing integrated healthcare services, with a focus on secondary and tertiary care.

The company operates seven multispeciality hospitals on a consolidated basis, with four pharmacies operating within its hospitals. The hospitals are located in Vadodara, Godhra, Bharuch, Borsad, and Anand with a total bed capacity of 490 beds, approved bed capacity of 445 beds and operational bed capacity of 340 beds.

The company categorizes its healthcare services as secondary services (which are surgical services) and tertiary services (which are super specialty surgical services).

Gujarat Kidney and Super Speciality financials

The company’s revenue from operations was Rs 40.24 crore for the year ended March 31, 2025, and its net profit was Rs 9.49 crore.

Its topline stood at Rs 15.26 crore during the three-month period ended June 30, 2025, and its net profit was Rs 5.40 crore.

Also Read: Zepto said to plan filing for $500 million India IPO next week

Lead managers

Nirbhay Capital Services Private Limited is the book-running lead manager, and MUFG Intime India Limited is the registrar of the offer.

Gujarat Kidney and Super Speciality IPO

The grey market premium (GMP) for the shares of Gujarat Kidney is yet to open.

(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)